Stock Rich List
#498 on the corporate holders of 813 holders

Casdin Capital, LLC

Director at GeneDx Holdings; Director at Standard BioTools; 10% owner at MaxCyte.

$175M
in disclosed stock, −$8.1M (−4.45%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
498th of 813
Companies held
3
Largest holding
WGS, 90.4% of total
Latest SEC filing
Feb 28, 2025
Listed but not counted
$98.9M

What the $175M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
GeneDx Holdings WGS
Class A Common Stock
Directly3,093,509$49.24$152M87.2%Form 4, Jun 4, 2024
MaxCyte MXCT
Common Stock, par value $0.01 per share
Directly10,000,000$1.28$12.8M7.3%Form 4, Oct 3, 2022
GeneDx Holdings WGS
Class A Common Stock
Indirectly (see filing footnote)
Reported jointly by 3 insiders; split evenly
111,048$49.24$5.5M3.1%Form 4, Jun 3, 2024
Standard BioTools LAB
Common Stock
Indirectly (see filing footnote)3,774,000$0.61$2.3M1.3%Form 4, Jun 18, 2024
Standard BioTools LAB
Common Stock
Directly2,806,470$0.61$1.7M1.0%Form 4, Feb 28, 2025

Share counts are the amounts Casdin Capital, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Casdin Capital, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Standard BioTools LAB
Common Stock
Through Casdin Partners Master Fund, L.P.
Held by a company or fund the insider manages
59,391,780$0.61$36.5M—Form 4, Feb 28, 2025
Standard BioTools LAB
Common Stock
Indirectly (see filing footnote)
Held by a company or fund the insider manages
46,730,821$0.61$28.7M—Form 4, Jun 18, 2024
GeneDx Holdings WGS
Class A Common Stock
Through CMLS Holdings LLC
Held by a company or fund the insider manages
432,902$49.24$21.3M—Form 4, Jun 3, 2024
Standard BioTools LAB
Common Stock
Through Casdin Private Growth Equity Fund II, L.P.
Held by a company or fund the insider manages
13,939,637$0.61$8.6M—Form 4, Feb 28, 2025
Tenaya Therapeutics TNYA
Common Stock
Through Casdin Capital, LLC
Held by a company or fund the insider manages
6,078,860$0.30$1.8M—Form 4, Nov 17, 2022
Standard BioTools LAB
Common Stock
Through Casdin Private Growth Equity Fund, L.P.
Held by a company or fund the insider manages
2,744,219$0.61$1.7M—Form 4, Feb 28, 2025
Standard BioTools LAB
Common Stock
Through Casdin Capital, LLC
Held by a company or fund the insider manages
545,000$0.61$335K—Form 4, Jun 18, 2024

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
495EnerVest Management GP, L.C.
Director, Magnolia Oil & Gas
$177M−$229K (−0.13%)
496Gmt Capital Corp
10% owner, Cracker Barrel Old Country Store
$176M−$6.5M (−3.59%)
497InnoCare Pharma Inc.
10% owner, Zenas BioPharma
$175M−$9.7M (−5.22%)
498Casdin Capital, LLC
Director, GeneDx Holdings
$175M−$8.1M (−4.45%)
499Ldb C LLC
Insider, Apollo Global Management
$174M−$1.5M (−0.83%)
500Ldb 2025 LLC
Insider, Apollo Global Management
$174M−$1.5M (−0.83%)
501Two Sigma Investments, LP
10% owner, Hamilton Insurance Group
$171M−$2.4M (−1.38%)

Other GeneDx Holdings insiders

All WGS insiders

Questions

How much stock does Casdin Capital, LLC own?

Casdin Capital, LLC holds $174,632,795 in listed stock based on SEC filings and current prices, mostly GeneDx Holdings (WGS). That ranks 498th on the Stock Rich List.

Is this Casdin Capital, LLC's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1534264.